Valamehr Bahram — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Valamehr Bahram has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $75K.

Profile

Valamehr Bahram

Bahram Valamehr is the President and CEO of Fate Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing programmed cellular immunotherapies for cancer and autoimmune disorders. He has been involved in the company's strategic direction and operational management.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-21FATEFATE THERAPEUTICS INCS — Open-market sale28.9K$1.88$54K
2026-01-16FATEFATE THERAPEUTICS INCA — Grant or award335.0K$0.00
2026-01-12FATEFATE THERAPEUTICS INCS — Open-market sale5.2K$1.07$6K
2025-08-04FATEFATE THERAPEUTICS INCS — Open-market sale14.5K$1.06$15K

Companies — Last 90 Days

Frequently Asked Questions

Who is Valamehr Bahram?

Bahram Valamehr is the President and CEO of Fate Therapeutics Inc, a clinical-stage biopharmaceutical company focused on developing programmed cellular immunotherapies for cancer and autoimmune disorders. He has been involved in the company's strategic direction and operational management.…

How many SEC Form 4 filings has Valamehr Bahram submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Valamehr Bahram been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($75K) across all tracked filings.

Where can I see all of Valamehr Bahram's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Valamehr Bahram profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.